SEARCH

SEARCH BY CITATION

References

  • 1
    Walker WJ, Goldin AR, Shaff MI, Allibone GW. Per catheter control of haemorrhage from the superior and inferior mesenteric arteries. Clin Radiol 1980;31: 7180.
  • 2
    Heaston DK, Mineau DE, Brown BJ, Miller FJ. Transcatheter arterial embolization for control of persistent massive puerperal hemorrhage after surgical hypogastric artery ligation. AJR 1979;133: 152154.
  • 3
    Walker WJ. Successful internal iliac artery embolisation with glue in a case of massive obstetric haemorrhage. Clin Radiol 1996;51: 442444.
  • 4
    Pelage JP, Le Dref O, Mateo J, et al. Life-threatening primary postpartum hemorrhage. Treatment with emergency selective arterial embolization. Radiology 1998;208: 359362.
  • 5
    Ravina JH, Herbreteau C, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995;346: 671672.
  • 6
    Bradley E, Reidy J, Forman R, Jarosz J, Braude P. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol 1998;105: 235240.
  • 7
    Worthington-Kirsch RL, Popky GL, Hutchins FL. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology 1998;208: 625629.
  • 8
    Goodwin SG, McLucas B, Lee M, et al. Uterine artery embolization for the treatment of uterine leiomyomata: midterm results. J Vasc Interv Radiol 1999;10: 11591165.
  • 9
    Spies JB, Scialli AR, Jha RC, et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata. J Vasc Interv Radiol 1999;10: 11491157.
  • 10
    Hutchins FLJr, Worthington-Kirsch RL, Berkowitz RP. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. J Am Assoc Gynecol Laparosc 1999;6: 279284.
  • 11
    Walker WJ, Green A, Sutton C. Bilateral uterine artery embolisation for myomata—results, complications and failures. Min Invas Ther Allied Technol 1999;8: 449454.
  • 12
    Pelage JP, Le Dref O, Soyer P, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and mid-term follow-up. Radiology 2000;215: 428431.
  • 13
    Brunereau L, Herbreteau D, Gallas S, et al. Uterine artery embolization in the primary treatment of leiomyomas. AJR 2000;175: 12671272.
  • 14
    Andersen PE, Lund N, Justesen P, Munk T, Elle B, Floridon C. Uterine artery embolization of symptomatic uterine fibroids. Acta Radiol 2001;42: 234238.
  • 15
    Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96: 351358.
  • 16
    Spies JB, Roth AR, Gonsalves SM, Murphy-Skrzyniarz KM. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J Vasc Interv Radiol 2001;12: 437442.
  • 17
    Pelage JP, Le Dref O, Soyer P, et al. Arterial anatomy of the female genital tract: variants and relevance to transcatheter embolization of the uterus. AJR 1999;172: 989994.
  • 18
    Waltman AC, Courey WR, Athanasoulis C, Baum S. Technique for left gastric artery catheterization. Radiology 1973;109: 732734.
  • 19
    Pelage JP, Soyer P, Le Dref O, et al. Uterine arteries: bilateral catheterization with a single femoral approach and a single 5-F catheter. Radiology 1999;210: 573575.
  • 20
    Togashi K, Ozasa H, Konishi I, et al. Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging. Radiology 1991;180: 8183.
  • 21
    Hricak H, Rubinstein LV, Ghermon GM, Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 1991;179: 829832.
  • 22
    Scoutt LM, McCarthy SM, Flynn SD, et al. Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Radiology 1995;194: 567572.
  • 23
    Hurst BS, Stakhouse DJ, Matthews ML, Marshburn PB. Uterine artery embolization for symptomatic uterine myomas. Fertil Steril 2000;74: 855869.
  • 24
    Siskin G, Eglander M, Stainken BF, Ahn J, Dowling K, Dolen EG. Embolic agents used for uterine fibroid embolization. AJR 2000;175: 767773.
  • 25
    Spies JB, Benenati JE, Worthington-Kirsch RL, Pelage JP. Initial US experience using trisacryl gelatin microspheres for uterine artery embolization for leiomyomata. J Vasc Interv Radiol 2001;12: 10591063.
  • 26
    Worthington-Kirsch R. Flow redistribution during uterine artery embolization for the management of symptomatic fibroids [editorial]. J Vasc Interv Radiol 1999: 10: 237238.
  • 27
    Wall BF, Hart D. Revised radiation doses for typical X-ray examinations. BJR 1997;70: 437439.
  • 28
    Nikolic B, Spies JB, Lundsten MJ, Abbara S. Patient radiation dose associated with uterine artery embolization. Radiology 2000;214: 121125.
  • 29
    Smith SJ, Sewall LE, Handelsman A. A clinical failure of uterine fibroid embolization due to adenomyosis. J Vasc Interv Radiol 1999;10: 11711174.
  • 30
    Siskin GP, Tublin ME, Stainken BF, Dowling K, Dolen EG. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. AJR 2001;177: 297302.
  • 31
    Burn PR, McCall JM, Chinn RJ, Vashisht A, Smith JR, Healy JC. Radiology 2000: 214: 729734.
  • 32
    McLucas B, Adler L, Perella R. Predictive factors for success in uterine fibroid embolization. Min Invas Ther Allied Technol 1999;8: 429432.
  • 33
    Watson GMT, Walker WJ. Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women's view of the success of treatment. Br J Obstet Gynaecol 2002;109: 129135.
  • 34
    Vashisht A, Studd J, Carey A, et al. Fatal septicaemia after fibroid embolisation. Lancet 1999;354: 307308.
  • 35
    McLucas B, Adler L, Perrella R. Uterine fibroid embolization: nonsurgical treatment for symptomatic fibroids. J Am Coll Surg 2001;192: 95105.
  • 36
    Baber R, Abdalla H, Studd J. The premature menopause. Prog Obstet Gynaecol 1991;9: 209226.
  • 37
    Cassou B, Derriennic F, Monfort C, Dell'Accio P, Touranchet A. Risk factors of early menopause in two generations of gainfully employed French women. Maturitas 1997;26: 165174.
  • 38
    Chrisman HB, Saker MB, Ryu RK, et al. The impact of uterine fibroid embolization on resumption of menses and ovarian function. J Vasc Interv Radiol 2000;11: 699703.
  • 39
    Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47: 94100.
  • 40
    Davies A, Magos AL. Indications and alternatives to hysterectomy. Baillieres Clin Obstet Gynaecol 1997;11: 6175.
  • 41
    Wallach EE. Myomectomy. In: ThompsonJD, RockJA, editors. Te Linde's Operative Gynaecology. Philadelphia : Lippincott, 1992: 647662.
  • 42
    Vessey MP, Villard-Mackintosh L, McPherson K, Coulter A, Yeates D. The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol 1992;99: 402407.
  • 43
    Wingo PA, Huezo CM, Rubin GL, Ory HW, Peterson HB. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 1985;152: 803808.
  • 44
    Walker WJ, Worthington-Kirsch R. Fatal septicaemia after fibroid embolisation. Lancet 1999;354: 1730.
  • 45
    Subramanian S, Spies JB. Uterine artery embolization for leiomyomata: resource use and cost estimation. J Vasc Interv Radiol 2001;12: 571574.
  • 46
    Stancato-Pasik A, Mitty H, Richard HM, et al. Obstetric embolotherapy: effect on menses and pregnancy. Radiology 1997;204: 791793.
  • 47
    Ravina JH, Ciraru-Vigneron N, Aymard A, Le Dref O, Merland JJ. Pregnancy after embolization of uterine myoma: report of 12 cases. Fertil Steril 2000;73: 12411243.